心力衰竭药物治疗新进展

被引：22

作者：

贾晨平

机构：

[1] 济宁市第一人民医院心内科

来源：

临床心血管病杂志 | 2017年 / 33卷 / 06期

关键词：

心力衰竭; 利钠肽; 肾素血管紧张素醛固酮系统; 肌球蛋白激动剂; 基因;

D O I：

10.13201/j.issn.1001-1439.2017.06.023

中图分类号：

R541.6 [血液循环衰竭];

学科分类号：

100201 [内科学];

摘要：

心力衰竭(心衰)的病理生理机制复杂,治疗药物涉及利钠肽系统、肾素-血管紧张素-醛固酮系统、作用体液因子药物、肌球蛋白激动剂、线粒体靶向药物和基因治疗等。本文针对心衰的药物治疗进展做一综述。

引用

页码：601 / 604

页数：4

共 20 条

[1]

基线血浆肾素活性可作为评估慢性心力衰竭的指标 [J].

杨丽萍 ;

孟赫禹 ;

杨玉双 ;

施凯耀 ;

刘冬娜 ;

刘龙 ;

孟繁波 .

临床心血管病杂志, 2017, 33 (02) :162-164

[2]

他汀治疗慢性心力衰竭的meta分析 [J].

贾晨平 ;

唐婷婷 ;

夏霓 ;

程翔 .

临床心血管病杂志, 2016, 32 (12) :1235-1241

[3]

Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure [J].

Sabbah, Hani N. ;

Gupta, Ramesh C. ;

Kohli, Smita ;

Wang, Mengjun ;

Hachem, Souheila ;

Zhang, Kefei .

CIRCULATION-HEART FAILURE, 2016, 9 (02) :1-10

[4]

Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta-Analysis of Randomized Trials [J].

Bonsu, Kwadwo Osei ;

Reidpath, Daniel Diamond ;

Kadirvelu, Amudha .

CARDIOVASCULAR THERAPEUTICS, 2015, 33 (06) :338-346

[5]

The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics [J].

Krum, Henry ;

McMurray, John J. V. ;

Abraham, William T. ;

Dickstein, Kenneth ;

Kober, Lars ;

Desai, Akshay S. ;

Solomon, Scott D. ;

Chiang, Yanntong ;

Gimpelewicz, Claudio ;

Reimund, Bernard ;

Ali, M. Atif ;

Tarnesby, Georgia ;

Massie, Barry M. .

EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (10) :1075-1083

[6]

Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones:biomarkers or mediators.[J].Alessia Buglioni;John C. Burnett.Clinica Chimica Acta.2015,

[7]

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure.[J].John J.V. McMurray;Milton Packer;Akshay S. Desai;Jianjian Gong;Martin P. Lefkowitz;Adel R. Rizkala;Jean L. Rouleau;Victor C. Shi;Scott D. Solomon;Karl Swedberg;Michael R. Zile.The New England Journal of Medicine.2014, 11

[8]

Serelaxin: A Novel Therapy for Acute Heart Failure with a Range of Hemodynamic and Non-Hemodynamic Actions [J].

Diez, Javier .

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (04) :275-285

[9]

Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition [J].

Fraccarollo, Daniela ;

Galuppo, Paolo ;

Motschenbacher, Stephanie ;

Ruetten, Hartmut ;

Schaefer, Andreas ;

Bauersachs, Johann .

BASIC RESEARCH IN CARDIOLOGY, 2014, 109 (04)

[10]

An overview of recent developments in the treatment of heart failure: update from the ESC Congress 2013.[J].Miroslava Valentova;Stephan von Haehling.Expert Opinion on Investigational Drugs.2014, 4

← 1 2 →